Dotmatics Acquires Virscidian, Expanding Expertise in Analytical Chemistry and Chromatography and Mass Spectrometry
Dotmatics has acquired Virscidian, a specialist in automated chromatography and mass spectrometry data processing, to enhance its Luma Scientific Intelligence Platform by integrating Virscidian’s Analytical Studio—featuring AI/ML-ready, high-fidelity analytical chemistry workflows for small molecule research—thereby expanding Dotmatics’ capabilities in automating laboratory data workflows and supporting high-throughput experimental design and quality control in scientific R&D.
Dotmatics’ 15th acquisition builds on its strategy to offer the industry’s best-in-class scientific applications built by scientists for scientists that integrate with the Luma Scientific Intelligence Platform.
BOSTON, MA - September 25, 2024 – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announced the successful acquisition of Virscidian, a specialized provider of analytical chemistry solutions and automated chromatography and mass spectrometry data processing. This acquisition, Dotmatics' 15th to date, strengthens Dotmatics’ ability to automate laboratory data workflows for experiments and complements its work to provide scientists with best-in-class scientific software that integrates with a comprehensive Scientific Intelligence Platform for multimodal scientific research and development.
Virscidian automates complex laboratory workflows using powerful data analysis algorithms in conjunction with an open architecture. Virscidian’s Analytical Studio produces high-fidelity, high-quality AI/ML-ready results for small molecule research. The addition of Virscidian’s Analytical Studio to Dotmatics’ portfolio enhances support for high-throughput experimental design, high-throughput purification, sample quality control, and other high content assays.
"Virscidian’s expertise in chromatography and mass spectrometry workflows and analytics for small molecule scientific discovery complements the solutions we offer through Protein Metrics for large molecule R&D," said Thomas Swalla, CEO of Dotmatics. "And now we can extend Virscidian’s capabilities by integrating it with Dotmatics Luma, which is helping our customers streamline complex workflows and enhance the accuracy and speed of their research through an AI-enabled lab-in-a-loop."
Virscidian Analytical Studio’s key modules—AS-Professional, AS-Experiment Builder, AS-Fraction Mapper, and AS-Sample Management Services—integrate with internal and third-party informatics environments, allowing scientists to optimize experimental designs, manage large datasets, and efficiently automate complex workflows.
“Joining Dotmatics represents an exciting new chapter for Virscidian,” said Joseph Simpkins, Founder and President of Virscidian. “We’ve built a powerful, flexible platform for laboratory informatics, and by combining it with Dotmatics’ existing tools, we can offer a more comprehensive solution to our customers. Together, we will enable scientists to unlock new possibilities in drug discovery and beyond.”
With this acquisition, Dotmatics builds on its strategy of offering best-in-class scientific applications built by scientists for scientists that work in harmony with an AI-native multimodal scientific intelligence platform, Luma. Dotmatics Luma™ helps scientists and administrators unify and analyze large volumes of data for better decision-making. It is an out-of-the-box, low-code SaaS platform that flexibly aggregates all relevant data into intelligent data structures enabling clean, reliable data analysis, and paves the way for meta-analysis and AI & ML-based algorithms.
About Virscidian
Virscidian is composed of experts in identifying, designing, and implementing decision-driven solutions to enhance productivity in biopharmaceutical and agricultural value chains. Virscidian’s scientific analytical desktop and enterprise software helps customers, independently of the vendor instrumentation, perform experiments such as automated reaction screening, end-to-end purification, affinity selection by mass spectrometry, compound quality control, and other high-throughput analytical techniques. Their solutions transform raw data into actionable intelligence that improves productivity and the quality of results, enabling chemists and project teams to make complex decisions from large amounts of data confidently. Their solutions are easily integrated and provide the critical decisions to drive some of the most sophisticated automation platforms in the world.
Marks Baughan Securities LLC served as exclusive financial advisor and JonesSpross, PLLC served as legal advisor to Virscidian, Inc. in this transaction.
About Dotmatics
Dotmatics is a leader in R&D scientific software connecting science, data, and decision-making. Its enterprise R&D platform and scientists’ favorite applications drive efficiency and accelerate innovation. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. Dotmatics has made 15 acquisitions since 2017. The company’s principal office is in Boston, with 14 offices and R&D teams located around the world.
Dotmatics is backed by Insight Partners, a leading global venture capital and private equity firm investing in high-growth technology and software scaleup companies. Learn more about Dotmatics, its platform, and applications including GraphPad Prism, Geneious, SnapGene, Protein Metrics, and LabArchives at www.dotmatics.com.
Media Contacts
Cory Edwards
Vice President, Corporate Communications
Dotmatics
media@dotmatics.com
Jerome Combes-Knoke
Senior Vice President, Strategy & Corporate Development
Dotmatics
corpdev@dotmatics.com
Related
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
How Luma Lab Connect Automates Lab Data Acquisition Across 100+ Instruments
Dotmatics Luma Lab Connect, part of the Dotmatics Luma multimodal scientific R&D platform, automates and streamlines the acquisition, management, and preparation of complex, multimodal lab data from over 100 diverse instruments and sources, addressing challenges of data security, integrity, and usability to enhance research productivity and enable FAIR data practices within a unified, low-code SaaS environment.
From Data Silos to AI-Ready Science: The Vision Behind Dotmatics Luma
Dotmatics Luma is a new, AI-driven, multimodal scientific platform designed to overcome data silos and fragmented R&D systems by uniting diverse scientific software and streamlining workflows across biologics, small molecule, and materials discovery, enabling smarter, faster, and more collaborative drug discovery and therapeutics development at the enterprise level.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Transforming Scientific Data Management with Dotmatics ELN
A leading India-based CRDMO overcame challenges of scaling and fragmented workflows by implementing Dotmatics ELN & Data Discovery Platform, enabling over 6,000 users to centralize chemical and biological data management, enhance collaboration through integrations with tools like SnapGene and Geneious, ensure compliance, and drive productivity and future growth across 2,000+ global researchers.